ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 135,80
0,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Actualités

CYTK Cytokinetics Inc

65,27
0,93 (1,45%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cytokinetics Inc CYTK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,93 1,45% 65,27 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
66,08 65,00 66,605 65,27 64,34
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/4/202422:00GLOBECytokinetics to Host Investor Event and Conference Call to..
24/4/202422:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10/4/202413:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05/4/202413:30GLOBECytokinetics Presents Additional 48-Week Data From..
02/4/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
01/4/202422:00GLOBECytokinetics to Participate in the 23rd Annual Needham..
25/3/202413:15GLOBECytokinetics Announces Four Upcoming Presentations at the..
07/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:21EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:00GLOBECytokinetics to Participate in March Investor Conferences
02/3/202400:47PRNUSSuper Micro Computer and Deckers Outdoor Set to Join S&P..
01/3/202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29/2/202413:30GLOBECytokinetics Joins Global Initiative to Recognize..
28/2/202413:30GLOBECytokinetics, The Mended Hearts, Inc. and WomenHeart..
27/2/202422:05EDGAR2Form 8-K - Current report
27/2/202422:00GLOBECytokinetics Reports Fourth Quarter 2023 Financial Results
14/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:03EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:00GLOBECytokinetics to Announce Fourth Quarter Results on February..
06/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:10EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:00GLOBECytokinetics to Participate in the Oppenheimer 34th Annual..
02/2/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:38EDGAR2Form 8-K - Current report
31/1/202422:02EDGAR2Form 144 - Report of proposed sale of securities
29/1/202413:30GLOBECytokinetics Announces Recipients of Its Sixth Annual..
25/1/202413:30GLOBECytokinetics Presents New Data at CMR 2024 From FOREST-HCM, ..
22/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:49EDGAR2Form 144 - Report of proposed sale of securities
18/1/202419:00GLOBECytokinetics Announces New Data From FOREST-HCM to be..
12/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:09EDGAR2Form 144 - Report of proposed sale of securities
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202419:15DJFRNovartis pourrait renoncer à un rachat de Cytokinetics -..
11/1/202419:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08/1/202419:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
04/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:02EDGAR2Form 144 - Report of proposed sale of securities
03/1/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
CYTK
Cytokinetics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés